KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Assets Average (2016 - 2025)

Historic Assets Average for BeOne Medicines (ONC) over the last 10 years, with Q3 2025 value amounting to $7.0 billion.

  • BeOne Medicines' Assets Average rose 2068.73% to $7.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 billion, marking a year-over-year increase of 2068.73%. This contributed to the annual value of $5.9 billion for FY2024, which is 389.61% up from last year.
  • BeOne Medicines' Assets Average amounted to $7.0 billion in Q3 2025, which was up 2068.73% from $6.1 billion recorded in Q2 2025.
  • Over the past 5 years, BeOne Medicines' Assets Average peaked at $8.3 billion during Q1 2022, and registered a low of $5.4 billion during Q3 2021.
  • Its 5-year average for Assets Average is $6.2 billion, with a median of $5.8 billion in 2023.
  • Per our database at Business Quant, BeOne Medicines' Assets Average soared by 10110.5% in 2021 and then crashed by 3091.73% in 2023.
  • Quarter analysis of 5 years shows BeOne Medicines' Assets Average stood at $6.9 billion in 2021, then fell by 11.68% to $6.1 billion in 2022, then decreased by 7.18% to $5.7 billion in 2023, then grew by 3.72% to $5.9 billion in 2024, then increased by 18.54% to $7.0 billion in 2025.
  • Its last three reported values are $7.0 billion in Q3 2025, $6.1 billion for Q2 2025, and $5.9 billion during Q1 2025.